The firm also nominated Stuart Strathdee and Ganesh Kishore to its board...Immune Design Corp., of Seattle, named Carlos V. Paya CEO and board member...Medivation Inc., of San Francisco, appointed Gretchen Burke vice president of finance and business processes

An item in the May 19, 2011, edition of BioWorld Today's Appointments and Advancements column should have said that Adimab LLC appointed Frances Heller to its board

Addex Pharmaceuticals Ltd., of Geneva, added Hoyoung Huh and Oleg Nodelman to its board...Aileron Therapeutics Inc., of Cambridge, Mass., named Julian Adams, Scott Kapnick and John H. McArthur to its board, and named Stephen W. Fesik, Robert H. Grubbs and Michael Hanley to its scientific advisory board

Neoprobe Corp., of Dublin, Ohio, appointed Mark Pykett president and CEO...Regulus Therapeutics Inc., of La Jolla, Calif., named Lars Karlsson vice president of immunology and fibrosis...Tobira Therapeutics Inc., of Manalapan, N.J., named Andrew Hindman president and CEO

Concert Pharmaceuticals Inc., of Lexington, Mass., appointed Mark Roessel vice president of regulatory affairs and quality assurance and named LuAnn Sabounjian vice president of clinical operations...Infinity Pharmaceuticals Inc., of Cambridge, Mass., appointed Joshua D. Hamermesh vice president of business and corporate development...Lightlake Therapeutics Inc., of London, appointed Cynthia McCormick as senior clinical and regulatory advisor

KaloBios Pharmaceuticals Inc., of South San Francisco, added Jonathan Leff as chief medical officer and named Gary A. Lyons to its board...Labopharm Inc., of Laval, Quebec, elected Mark D'Souza president, CEO and board member...Pro-Pharmaceuticals Inc., of Newton, Mass., named Peter G. Traber president and CEO

Hospira Inc., of Lake Forest, Ill., elected F. Michael (Mike) Ball CEO and board member...ITherX Pharmaceuticals Inc., of San Diego, named Stefan Zeuzem chairman of its scientific and clinical advisory board

Addex Pharmaceuticals Ltd., of Geneva, proposed adding Hoyoung Huh and Oleg Nodelman to the board...Codexis Inc., of Redwood City, Calif., named Jacques Beaudry-Losique vice president of corporate development and strategy

Pearl Therapeutics Inc., of Redwood City, Calif., appointed Chuck Bramlage president and CEO...Plethora Solutions Holdings plc, of London, appointed Richard Horsman to its board and named Billy Hargan vice president of commercial operations...Protox Therapeutics Inc., of Vancouver, British Columbia, named William Rohn and Arnit Sobti to its board

BioNanomatrix Inc., of Philadelphia, named R. Erik Holmlin president, CEO and director...It also added Michael Handelman as chief financial officer, treasurer and secretary...Medgenics Inc., of Misgav, Israel, added Isaac Blech and Raymond Dean Hautamaki to its board

Oncos Therapeutics, of Helsinki, Finland, appointed Jonathan Knowles and Robert Burns to its board...Soligenix Inc., of Princeton, N.J., appointed Kevin Horgan senior vice president and chief medical officer...Topaz Pharmaceuticals Inc., of Horsham, Pa., appointed Mark Strobeck vice president and chief business officer

executive vice president and chief operating officer and named John A. Bellano senior vice president of sales and commercial programs

The firm also named Lori M. Henderson vice president, general counsel and secretary...Anadys Pharmaceuticals Inc., of San Diego, named Kevin L. Eastwood senior vice president of corporate development, promoted James Appleman to senior vice president of research and chief scientific officer, appointed James L. Freddo to the board and named Stelios Papadopoulos chairman...AspenBio Pharma Inc., of Castle Rock, Colo., added Erik S. Miller as vice president of marketing and business development

Markus Leyck Dieken senior vice president and general manager, Germany...and Manuela Maronati vice president, sales and marketing, Europe

Receptos Inc., of San Diego, appointed Faheem Hasnain president, CEO and board member...Selvita, of Krakow Poland, appointed Piotr Prelich vice president of sales and marketing...Topaz Pharmaceuticals Inc., of Horsham, Pa., appointed Bob Radie president and CEO

OctoPlus NV, of Leiden, the Netherlands, named Jan Hendrik Egberts and nominated him for appointment as CEO...Optimer Pharmaceuticals Inc., of San Diego, named Kurt Hartman general counsel and access...Protox Therapeutics Inc., of Vancouver, British Columbia, named Lars Ekman chairman and added Jonathan Leff and Nishan de Silva to the board

Celtaxys Inc., of Atlanta, named Michael Hanley CEO and chairman...Codexis Inc., Redwood City, Calif., named William Rothwell vice president and general manager of Biobased Chemicals...Cytomedix Inc., of Gaithersburg, Md., formed a scientific advisory board with the appointments of Marissa Carter, Jean de Leon, Vickie R. Driver, Peter A. M. Everts, Will W. Li and Thomas E. Serena

Roche, of Nutley, N.J., named Jacques Banchereau senior vice president and head of the inflammation and virology discovery and translational areas

Neovacs, of Paris, appointed Florence Hocdee-Leroy communications and investor relations director...Oligomerix Inc., of New York, appointed Vic Micati chairman and named Jack Pasini chief commercial officer and board member